Ganoderic acids suppress growth and angiogenesis by modulating the NF-κB signaling pathway in breast cancer cells

International Journal of Clinical Pharmacology and Therapeutics

Volumn 50, Issue 10, 2012, Pages 712-721

  Li, Funian ^a   Wang, Yu ^a   Wang, Xingang ^a   Li, Jianguo ^b   Cui, Haining ^b   Niu, Min ^c  

^a QINGDAO UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Qing Dao University   (China)

Author keywords

Angiogenesis; Apoptosis; Breast carcinoma; Ganoderic acid; NF B

Indexed keywords

CYCLIN D1; GANODERIC ACID; GANODERMA LUCIDUM EXTRACT; GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MYC PROTEIN; PROTEIN BCL 2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYCLIN D1 GENE; DOWN REGULATION; DRUG DOSE COMPARISON; GEL MOBILITY SHIFT ASSAY; GENE; HUMAN; HUMAN CELL; IL6 GENE; IL8 GENE; IN VIVO STUDY; INHIBITION KINETICS; MALE; MMP 9 GENE; MOUSE; NONHUMAN; ONCOGENE C MYC; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; SIGNAL TRANSDUCTION; TUMOR GROWTH; VEGF GENE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRITERPENES;

EID: 84867243066     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201663     Document Type: Article

References (33)

1. Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. Breast cancer. Lancet. 2005; 365: 1727-1741. doi:10.1016/S0140-6736(05)66546-4 PubMed (Pubitemid 40719108)
2. Clarke R, Leonessa F, Welch JN, Skaar TC. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev. 2001; 53: 25-71. PubMed (Pubitemid 32173107)
3. Hoffmann J, Sommer A. Steroid hormone receptors as targets for the therapy of breast and prostate cancer-recent advances, mechanisms of resistance, and new approaches. J Steroid Biochem Mol Biol. 2005; 93: 191-200. doi:10.1016/j.jsbmb.2004.12.002 PubMed (Pubitemid 40602492)
4. Shi L, Ren A, Mu D, Zhao M. Current progress in the study on biosynthesis and regulation of ganoderic acids. Appl Microbiol Biotechnol. 2010; 88: 1243-1251. doi:10.1007/s00253-010-2871-1 PubMed
5. Wang G, Zhao J, Liu J, Huang Y, Zhong JJ, Tang W. Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo. Int Immunopharmacol. 2007; 7: 864-870. doi:10.1016/j.intimp.2007.02.006 PubMed (Pubitemid 46635284)
6. Chen NH, Liu JW, Zhong JJ. Ganoderic acid Me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression. J Pharmacol Sci. 2008; 108: 212-216. doi:10.1254/jphs.SC0080019 PubMed
7. Wang JL, Li YB, Liu RM, Zhong JJ. A new ganoderic acid from Ganoderma lucidum mycelia. J Asian Nat Prod Res. 2010; 12: 727-730. doi:10.1080/10286020. 2010.493506 PubMed
8. Zhou L, Shi P, Chen N, Zhong J. Ganoderic acid Me induces apoptosis through mitochondria dysfunctions in human colon carcinoma cells. Process Biochem. 2011; 46: 219-225. doi:10.1016/j.procbio.2010.08.014
9. Jiang J, Grieb B, Thyagarajan A, Sliva D. Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. Int J Mol Med. 2008; 21: 577-584. PubMed
10. Jiang J, Slivova V, Sliva D. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NFkappaB signaling. Int J Oncol. 2006; 29: 695-703. PubMed
11. Ding N, Yang Q, Huang SS, Fan LY, Zhang W, Zhong JJ, Cao CX. Separation and determination of four ganoderic acids from dried fermentation mycelia powder of Ganoderma lucidum by capillary zone electrophoresis. J Pharm Biomed Anal. 2010; 53: 1224-1230. doi:10.1016/j.jpba.2010.07.025 PubMed
12. Ohno M, Abe T. Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6). J Immunol Methods. 1991; 145: 199-203. doi:10.1016/0022-1759(91)90327-C PubMed
13. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991; 19: 2499. doi:10.1093/nar/19.9.2499 PubMed
14. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA. 1989; 86: 2336-2340. doi:10.1073/pnas.86.7.2336 PubMed (Pubitemid 19102503)
15. Zheng Wang, Jian Zhou, Jia Fan, Shuang-Jian Qiu, Yao Yu, Xiao-Wu Huang, Zhao-You Tang. Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma.Clin Cancer Res August. 2008,14;5124-5130.
16. Matsumoto G, Namekawa J, Muta M, Nakamura T, Bando H, Tohyama K, Toi M, Umezawa K. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo. Clin Cancer Res. 2005; 11: 1287-1293. PubMed (Pubitemid 40175782)
17. Lee SO, Jeong YJ, Kim M, Kim CH, Lee IS. Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression. Biochem Biophys Res Commun. 2008; 366: 1019-1024. doi:10.1016/j.bbrc.2007.12.068 PubMed
18. Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res. 2000; 60: 5334-5339. PubMed
19. Kuo PL, Hsu YL, Lin TC, Tzeng WS, Chen YY, Lin CC. Rugosin E, an ellagitannin, inhibits MDA-MB- 231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor- kappaB signaling pathway. Cancer Lett. 2007; 248: 280-291. doi:10.1016/j.canlet.2006.08.006 PubMed
20. Maier HJ, Schmidt-Strassburger U, Huber MA, Wiedemann EM, Beug H, Wirth T. NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells. Cancer Lett. 2010; 295: 214-228. doi:10.1016/j.canlet.2010.03.003 PubMed
21. Yan X, Shen H, Jiang H, Hu D, Zhang C, Wang J, Wu X. External Qi of Yan Xin Qigong Induces apoptosis and inhibits migration and invasion of estrogen-independent breast cancer cells through suppression of Akt/NF-κB signaling. Cell Physiol Biochem. 2010; 25: 263-270. doi:10.1159/000276560 PubMed
22. Wong JH, Lui VW, Umezawa K, Ho Y, Wong EY, Ng MH, Cheng SH, Tsang CM, Tsao SW, Chan AT. A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells. Cancer Lett. 2010; 287: 23-32. doi:10.1016/j.canlet.2009.05.022 PubMed
23. Kim A, Kim MJ, Yang Y, Kim JW, Yeom YI, Lim JS. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Carcinogenesis. 2009; 30: 927-936. doi:10.1093/carcin/ bgp072 PubMed
24. Mao Z, Ma X, Rong Y, Cui L, Wang X, Wu W, Zhang J, Jin D. Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E-cadherin via the NF-κB pathway. Cancer Sci. 2011; 102: 104-110. doi:10.1111/j.1349-7006.2010.01746.x PubMed
25. Uchino R, Madhyastha R, Madhyastha H, Dhungana S, Nakajima Y, Omura S, Maruyama M. NFkappaB-dependent regulation of urokinase plasminogen activator by proanthocyanidin-rich grape seed extract: effect on invasion by prostate cancer cells. Blood Coagul Fibrinolysis. 2010; 21: 528-533. doi:10.1097/MBC.0b013e- 32833a9b61 PubMed
26. Yuen JW, Gohel MD. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer. 2005; 53: 11-17. doi:10.1207/s15327914nc5301-2 PubMed (Pubitemid 43068549)
27. Mahajna J, Dotan N, Zaidman BZ, Petrova RD, Wasser SP. Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum. Nutr Cancer. 2009; 61: 16-26. doi:10.1080/01635580802379323 PubMed
28. Weng CJ, Yen GC. The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clin Exp Metastasis. 2010; 27: 361-369. doi:10.1007/s10585-010-9334- z PubMed
29. Chen NH, Liu JW, Zhong JJ. Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression. Pharmacol Rep. 2010; 62: 150-163. PubMed
30. Karin M, CaoY, Greten FR, Li ZW. NF-κB in cancer:from innocent bystander to major culprit. Nat Rev Cancer. 2002; 2: 301-310. doi:10.1038/nrc780 PubMed
31. Garg A, Aggarwal BB. Nuclear transcription factor- kappaB as a target for cancer drug development. Leukemia. 2002; 16: 1053-1068. doi:10.1038/sj.leu. 2402482 PubMed (Pubitemid 34618844)
32. Yokoe T, Iino Y, Morishita Y. Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report. Breast Cancer. 2000; 7: 187-190. doi:10.1007/BF02967458 PubMed
33. De Larco JE, Wuertz BR, Rosner KA, Erickson SA, Gamache DE, Manivel JC, Furcht LT. A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol. 2001; 158: 639-646. doi:10.1016/S0002- 9440(10)64005-9 PubMed (Pubitemid 32158624)